ContextPrescription drugs are instrumental to managing and preventing chronic disease.
Recent changes in US prescription drug cost sharing could affect access to them …

How Patient Cost-Sharing Trends Affect Adherence and Outcomes - PMC Back to Top Skip to
main content NIH NLM Logo Access keys NCBI Homepage MyNCBI Homepage Main Content …

Purpose The introduction of imatinib, a tyrosine kinase inhibitor (TKI), has greatly increased
survival for patients with chronic myeloid leukemia (CML). Conversely, nonadherence to …

BACKGROUND: Statins substantially reduce the risk of cardiovascular disease and are
generally well-tolerated. Despite this, many patients discontinue therapy. A better …

Medical practice in the United States has changed dramatically in the last several decades,
especially with more frequent use of prescription drugs. A higher volume and better-quality …

In order to be approved for marketing in the United States, drugs must be proven to be safe
and effective using “adequate and well‐controlled investigations.” This chapter clarifies the …

Introduction: Opioid-related mortality appears to be increasing in Canada. We examined the
true extent of the problem and the impact of the introduction of long-acting oxycodone …

We estimate the effect of information and expertise on consumers' willingness to pay for
national brands in physically homogeneous product categories. In a detailed case study of …

ContextMany health plans have instituted more cost sharing to discourage use of more
expensive pharmaceuticals and to reduce drug spending. ObjectiveTo determine how …

Abstract In the United States, two patients with the same medical condition can receive
drastically different treatments. In addition, the same patient can walk into two physicians' …